• Citer

Promising results with exemestane in the first-line treatment of metastatic breast cancer: a randomized phase II EORTC trial with a tamoxifen control.

par Paridaens, R. ;Dirix, Luc Y;Beex, Louk;Nooij, Marianne;Cufer, T;Lohrisch, C;Biganzoli, Laura ;Van Hoorebeeck, Irène;Duchateau, L;Lobelle, Jean Pierre;Piccart-Gebhart, Martine
Référence Clinical breast cancer, 1 Suppl 1, page (S19-S21)
Publication Publié, 2000-09

Article révisé par les pairs

• Détails
• Contenu

Titre:	Promising results with exemestane in the first-line treatment of metastatic breast cancer: a randomized phase II EORTC trial with a tamoxifen control.
Auteur:	Paridaens, R.; Dirix, Luc Y; Beex, Louk; Nooij, Marianne; Cufer, T; Lohrisch, C; Biganzoli, Laura; Van Hoorebeeck, Irène; Duchateau, L; Lobelle, Jean Pierre; Piccart-Gebhart, Martine
Informations sur la publication:	Clinical breast cancer, 1 Suppl 1, page (S19-S21)
Statut de publication:	Publié, 2000-09
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Administration, Oral
	Androstadienes -- adverse effects
	Androstadienes -- therapeutic use
	Antineoplastic Agents, Hormonal -- therapeutic use
	Aromatase Inhibitors -- adverse effects
	Aromatase Inhibitors -- therapeutic use
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- pathology
	Disease Progression
	Female
	Humans
	Neoplasm Metastasis
	Tamoxifen -- therapeutic use
	Treatment Outcome
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1526-8209
	info:pmid/11970745